DIABETES-CENTER-BERNE
15.6.2021 14:50:06 CEST | Business Wire | Press release
In the last few years, diabetes technology has made enormous progress in improving the lives of people living with diabetes. However, there is still a great unmet need for innovative technology solutions that help ease the burden of diabetes and improve the lives of people who have it. One of these unmet needs is better glucose measurement. People with diabetes are asking for methods of glucose measurement that are more convenient, less invasive and more affordable. Hence why Diabetes Center Berne (DCB) is setting this challenge.
THE TOPIC
“Can your idea change glucose measurement forever?”
BACKGROUND
DCB is looking for innovators, co-creators, scientists and members of the diabetes community from around the world to join our open call for ideas and be part of an innovative community at the forefront of diabetes technology. Whether you are a start-up, a healthcare professional, a researcher or an individual, if you have an idea or insight into how to improve the lives of people living with diabetes, DCB wants to hear from you!
SUMBISSION DEADLINE
Ideas can be submitted up until 30 June 2021 via the sign-up page: dcb-innovation-challenge.com
ABOUT DCB
The Diabetes Center Berne Foundation is a private, independent Swiss foundation, established in 2017. It helps research projects and entrepreneurial ideas to grow. Based in Switzerland, Diabetes Center Berne provides projects around the world with expertise, access to clinical research facilities and its own laboratories and workspaces, as well as financial resources. It is located at the sitem
on the Insel Campus in the Swiss capital Berne. DCB works in close scientific partnership with the Department of Diabetes, Endocrinology, Clinical Nutrition and Metabolism of Bern University Hospital (UDEM
), a university hospital with a stellar international reputation in the field of diabetes technology.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210615005747/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Cambridge International AS & A Level Entries Grow 5% Amid Rising Higher Education Demand for Flexible, Skills-Based Qualifications11.8.2026 08:03:00 CEST | Press release
Around 368,000 Cambridge International AS & A Level students receive results todayNearly 705,000 students in 148 countries sat Cambridge exams in the June series, with total entries up to 1.7 million Cambridge International Education (Cambridge) has begun releasing the results of its June 2026 exam series to students worldwide. Entries for Cambridge International AS & A Levels rose 5% on last year, with almost 368,000 students in 3492 schools worldwide receiving Cambridge International AS & A Level results today. This continued growth reflects the increasing global demand for qualifications that provide a trusted route to higher education. Recognised by more than 2500 universities worldwide, Cambridge International AS & A Levels equip learners with the academic knowledge, independent thinking and problem-solving skills needed to succeed at university and beyond. Their acceptance now extends well beyond traditional destinations such as the UK, the US, Canada and Australia, with leading
Galderma Receives European Union Approval for Restylane® Shaype™: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping11.8.2026 07:00:00 CEST | Press release
Galderma has introduced the first-and-only shaper to the hyaluronic acid (HA) market with Restylane Shaype, now approved in the European Union (EU) for chin augmentation1 Restylane Shaype is the firmest HA gel available, powered by new NASHA HD™ technology, engineered to build and shape on bone for instant, natural-looking lower-face shaping from any angle1-3 It is the latest addition to the innovative Restylane portfolio – the world’s most diverse range of hyaluronic acid injectables designed to meet evolving aesthetic needs, backed by three decades of science4 Galderma (SIX: GALD) today announced that Restylane Shaype has been approved in the EU under the Medical Device Regulation for temporary augmentation of the chin region. Engineered for deep injection to build and shape on bone, Restylane Shaype delivers a unique bone-mimicking effect, enabling immediate, natural-looking structural enhancement in the lower face without surgery.1-3 This press release features multimedia. View the
Stonebranch is Again Named a Leader in the 2026 Gartner® Magic Quadrant™ for Service Orchestration and Automation Platforms (SOAPs)10.8.2026 17:00:00 CEST | Press release
Gartner recognizes Stonebranch as a Leader for the third consecutive year based on Completeness of Vision and Ability to Execute. Stonebranch, a leading provider of service orchestration and automation solutions, today announced that it has once again been positioned by Gartner as a Leader in the Magic Quadrant for Service Orchestration and Automation Platforms (SOAPs) for its offering, Universal Automation Center™ (UAC).1 “We’re pleased to be recognized as a Leader for the third year in a row,” said Giuseppe Damiani, CEO at Stonebranch. “To us, this recognition reflects our advancements in helping enterprises orchestrate increasingly complex IT operations with confidence. As organizations modernize their automation strategies and adopt AI, UAC provides the centralized orchestration control plane required to unify traditional automation with AI models and agentic systems. With built-in capabilities like Robi AI, UAC’s agentic copilot, we’re making it easier than ever for teams to build
Frontgrade Expands Huntsville Presence with Advanced R&D Center Supporting Next-Generation Space and Defense Missions10.8.2026 16:09:00 CEST | Press release
New facility in Cummings Research Park brings engineering closer to customers while advancing mission processing technologies and strengthening Frontgrade's long-term investment in Huntsville Frontgrade Technologies ("Frontgrade"), a leading provider of mission-critical electronics and integrated technologies, today announced the opening of its eighth U.S. location in Huntsville, Alabama. Located in Cummings Research Park, the new Advanced Research & Development Center will accelerate the development of next-generation mission processing technologies supporting critical space, defense, intelligence, and national security missions. The Huntsville center expands Frontgrade's engineering capabilities while placing research teams closer to customers, government organizations, industry partners, and leading academic institutions. By working within one of the nation's premier aerospace and defense ecosystems, Frontgrade will accelerate technology development, strengthen customer collaboratio
Brightfin Appoints Preeti Shukla as Chief Product and AI Officer10.8.2026 15:00:00 CEST | Press release
Enterprise AI SaaS leader to accelerate Brightfin's AI-Native platform for IT financial management Brightfin, the only IT Financial Management (ITFM) and Technology Expense Management solution built natively on ServiceNow, today announced the appointment of Preeti Shukla as Chief Product and AI Officer (CPAIO). In this newly created role, Shukla will lead product strategy and artificial intelligence across the Brightfin platform, advancing the company's mission to make every technology decision grounded in financial truth, operational clarity, and intelligent automation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260810283143/en/ Preeti Shukla, CPAIO of Brightfin Shukla brings two decades of experience building and scaling customer-facing, enterprise-grade B2B SaaS, fintech, and marketplace products across Fortune 100 companies and high-growth startups, including leadership roles at Workday and Oracle. A recognized autho
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom